Composition Each tablet contain: Protecarpine 600 mg. Properties Microfibre contains Protecarpine which is extracted from wheat bran – retains its quality & does not disintegrate neither in acidic, nor in alkaline environment. Its composition is stable and constant. It has as primary effects prevention of gastro. Intestinal catarrh resulting from the low intake of dietary …
Alphastat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Alphastat should be discontinued after 12 weeks if patients have been unable to lose …
Zenicool is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Zenicool should be discontinued after 12 weeks if patients have been unable to lose …
Smart_Look is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Smart_Look should be discontinued after 12 weeks if patients have been unable to lose …
Easy_Slim is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Easy_Slim should be discontinued after 12 weeks if patients have been unable to lose …
Easy_Slim (120mg Orlistat capules) – For Weight Loss & Weight Maintenance Read More »
Xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Xenical should be discontinued after 12 weeks if patients have been unable to lose …
Xenical (120mg Orlistat capules) – Cut 30% of Dietary Fat Read More »
Uni_Cal is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Uni_Cal should be discontinued after 12 weeks if patients have been unable to lose …
Uni_Cal (120mg Orlistat capules) – Prevent Fat Absorption Read More »
Thincal is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Thincal should be discontinued after 12 weeks if patients have been unable to lose …
Staticap is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Staticap should be discontinued after 12 weeks if patients have been unable to lose …
Staticap (120mg Orlistat capules) – 25% of Dietary Fat Off Read More »
Slim_Well is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Slim_Well should be discontinued after 12 weeks if patients have been unable to lose …
Slim_Well (120mg Orlistat capules) – Limit Fat Absorption Read More »